LPCAT2 controls chemoresistance in colorectal cancer

Lipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine...

Full description

Bibliographic Details
Main Authors: Alexia Karen Cotte, Virginie Aires, François Ghiringhelli, Dominique Delmas
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:http://dx.doi.org/10.1080/23723556.2018.1448245
_version_ 1797677155722723328
author Alexia Karen Cotte
Virginie Aires
François Ghiringhelli
Dominique Delmas
author_facet Alexia Karen Cotte
Virginie Aires
François Ghiringhelli
Dominique Delmas
author_sort Alexia Karen Cotte
collection DOAJ
description Lipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine acyltransferase 2 (LPCAT2) enzyme expression. We also showed that chemotherapy-induced LD accumulation counteracts intrinsic and extrinsic cancer cell death activation.
first_indexed 2024-03-11T22:40:56Z
format Article
id doaj.art-9000032af48e4fccb395f82ac04468d6
institution Directory Open Access Journal
issn 2372-3556
language English
last_indexed 2024-03-11T22:40:56Z
publishDate 2018-05-01
publisher Taylor & Francis Group
record_format Article
series Molecular & Cellular Oncology
spelling doaj.art-9000032af48e4fccb395f82ac04468d62023-09-22T09:10:59ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562018-05-015310.1080/23723556.2018.14482451448245LPCAT2 controls chemoresistance in colorectal cancerAlexia Karen Cotte0Virginie Aires1François Ghiringhelli2Dominique Delmas3University of Bourgogne-Franche ComtéUniversity of Bourgogne-Franche ComtéUniversity of Bourgogne-Franche ComtéUniversity of Bourgogne-Franche ComtéLipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine acyltransferase 2 (LPCAT2) enzyme expression. We also showed that chemotherapy-induced LD accumulation counteracts intrinsic and extrinsic cancer cell death activation.http://dx.doi.org/10.1080/23723556.2018.1448245colorectal cancerchemoresistanceimmunogenic cell deathlipid dropletslpcat2
spellingShingle Alexia Karen Cotte
Virginie Aires
François Ghiringhelli
Dominique Delmas
LPCAT2 controls chemoresistance in colorectal cancer
Molecular & Cellular Oncology
colorectal cancer
chemoresistance
immunogenic cell death
lipid droplets
lpcat2
title LPCAT2 controls chemoresistance in colorectal cancer
title_full LPCAT2 controls chemoresistance in colorectal cancer
title_fullStr LPCAT2 controls chemoresistance in colorectal cancer
title_full_unstemmed LPCAT2 controls chemoresistance in colorectal cancer
title_short LPCAT2 controls chemoresistance in colorectal cancer
title_sort lpcat2 controls chemoresistance in colorectal cancer
topic colorectal cancer
chemoresistance
immunogenic cell death
lipid droplets
lpcat2
url http://dx.doi.org/10.1080/23723556.2018.1448245
work_keys_str_mv AT alexiakarencotte lpcat2controlschemoresistanceincolorectalcancer
AT virginieaires lpcat2controlschemoresistanceincolorectalcancer
AT francoisghiringhelli lpcat2controlschemoresistanceincolorectalcancer
AT dominiquedelmas lpcat2controlschemoresistanceincolorectalcancer